Results 101 to 110 of about 57,488 (195)

Mature results from EORTC 22033: Implications of inferior results with monotherapy for grade 2 gliomas. [PDF]

Neuro Oncol
Kinslow CJ, Schiff D.
europepmc   +1 more source

The critical issue of grade 2 vs grade 3 in IDH-mutant gliomas. [PDF]

Neuro Oncol
Ng HK.
europepmc   +1 more source

Integrative Single-Cell, Spatial, and Bulk Transcriptomics Characterizes an Outcome-Associated, Spatially Organized Mesenchymal Program in <i>IDH</i>-Mutant Glioma. [PDF]

Biology (Basel)
Vuyyuru KH, Daggubati V, Karlapudi AP, Ahmad K.   +3 more
europepmc   +1 more source

Triptychs for a future. Moral forces in the Revista de Filosofía

Estudios de Teoría Literaria
It is interesting to think about the proposal of philosophy that Ingenieros rehearses from his last writings, in particular the texts published in the Revista de Filosofía, which would later be gathered in Las fuerzas morales.
María Carla Galfione
doaj  

Mitochondrial Metabolic Reprogramming in Glioma: Mechanisms of Tumorigenesis and Implications for Clinical Therapy. [PDF]

CNS Neurosci Ther
Jiang L, Li M, Li Z, Liu Q, Li Y.
europepmc   +1 more source

IDH-Mutant Diffuse Glioma: From Metabolic Origins to Targeted Therapy. [PDF]

J Clin Med
Urbanic-Purkart T.
europepmc   +1 more source

Diagnostic Accuracy of APTw and NOEw MRI Metrics for IDH Mutation and 1p/19q Codeletion Prediction in Gliomas. [PDF]

NMR Biomed
Cadin C, Casagranda S, Lejeune FX, Golse M, Mathon B, Dipasquale O, Papageorgakis C, Zucchelli M, Mandonnet E, Lehéricy S, Bielle F, Sanson M, Liebig P, Zaiss M, Nichelli L, Branzoli F.   +15 more
europepmc   +1 more source

Two-decade clinicopathological spectrum of gliomas at a tertiary center in LMIC: histological profile and the molecular diagnostic gap. [PDF]

Front Oncol
Daoud SS, Hulliel AF, Jarrar S, Jaradat A, Alababneh LA, Abdallah A.   +5 more
europepmc   +1 more source

Diffusion histogram analysis predicts progression-free survival in contrast enhancing recurrent IDH mutant gliomas treated with bevacizumab. [PDF]

J Neurooncol
Loxterkamp E, Luo A, Sanvito F, Le CT, Raymond C, Yang C, Prins TJ, Fisher A, Salamon N, Liau LM, Chong RA, Nghiemphu PL, Nathanson DA, Cloughesy TF, Lai A, Ellingson BM.   +15 more
europepmc   +1 more source

PTEN homozygous deletion is a negative prognostic factor in tumor treating fields-treated glioblastoma, IDH wildtype patients. [PDF]

Brain Pathol
Nückles J, Jelgersma C, Siewert C, Osberg B, Schmid S, Koch A, Perez E, Teichmann D, Misch M, Karbe AG, Ukrow S, Harter PN, Stassart RM, Vajkoczy P, Onken J, Capper D.   +15 more
europepmc   +1 more source